{
    "2018-09-14": [
        [
            {
                "time": "",
                "original_text": "健帆生物：肾病领域确定性强，肝病领域成长可期",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "肾病领域",
                        "确定性强",
                        "肝病领域",
                        "成长可期"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}